Skip to content

CSL Ltd Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Tue, Feb 9, 2027 · estimates and history

CSL Ltd · E.CSL.AU · Australia
Use symbol E.CSL.AU in our API & Excel add-in to retrieve this data ↓
197.29
(-0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 75%
Bubble Risk LOW
Realised Volatility (20D) 16.22%

CSL Ltd Forecast

CSL Ltd short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 16.2% a year, a typical one-standard-deviation range is 192.78–201.80 over a week, 188.05–206.53 over a month and 165.30–229.28 over a year. (Signals as of 21 Nov 2026.)

CSL Ltd Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
CSL Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
CSL Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
CSL Ltd
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
CSL Ltd
P/S
3.71x
Mid-range vs own history
QoQ +17.2%
YoY +5.3%
now 3.70881.78 low3.81 high
ⓘP/S As of 22 Nov 2026.See CSL Ltd returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
CSL Ltd
P/B
6.39x
Mid-range vs own history
QoQ +17.2%
YoY +42.4%
now 6.38822.52 low6.57 high
ⓘP/B As of 22 Nov 2026.See CSL Ltd returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
CSL Ltd
EV/EBITDA
13.10x
Mid-range vs own history
QoQ +15.4%
YoY +14.8%
now 13.09796.32 low13.44 high
ⓘEV/EBITDA As of 22 Nov 2026.See CSL Ltd returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
CSL Ltd
EV/Sales
4.08x
Mid-range vs own history
QoQ +15.4%
YoY +4.4%
now 4.0772.21 low4.18 high
ⓘEV/Sales As of 22 Nov 2026.See CSL Ltd returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
CSL Ltd
FCF Yield
5.7%
Strong vs own history
QoQ −14.7%
YoY +7.0%
now 5.74065.15 low9.92 high
ⓘFCF Yield As of 22 Nov 2026.See CSL Ltd returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
CSL Ltd
Earnings Yield
-0.9%
Weak vs own history
QoQ −14.7%
YoY −120.4%
now -0.9414-1.63 low8.63 high
ⓘEarnings Yield As of 22 Nov 2026.See CSL Ltd returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
CSL Ltd
Dividend Yield
2.4%
Mid-range vs own history
QoQ −14.7%
YoY −8.4%
now 2.42872.36 low5.4 high
ⓘDividend Yield As of 22 Nov 2026.See CSL Ltd returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
CSL Ltd
Market Cap
$94.5B
Mid-range vs own history
QoQ +17.2%
YoY +8.6%
now 94484.548546,963 low97,181 high
ⓘMarket Cap As of 22 Nov 2026.See CSL Ltd returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
CSL Ltd
Net Debt
$9.4B
Mid-range vs own history
QoQ 0.0%
YoY −1.1%
now 9378.9379,379 low11,434 high
ⓘNet Debt As of 22 Nov 2026.See CSL Ltd returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
CSL Ltd
Net Debt / EBITDA
1.18x
Mid-range vs own history
QoQ 0.0%
YoY +5.5%
now 1.18271.12 low1.24 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See CSL Ltd returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
CSL Ltd
Current Ratio
2.21x
Mid-range vs own history
QoQ 0.0%
YoY −10.2%
now 2.20992.21 low2.57 high
ⓘCurrent Ratio As of 22 Nov 2026.See CSL Ltd returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
CSL Ltd
Quick Ratio
0.97x
Mid-range vs own history
QoQ 0.0%
YoY −13.1%
now 0.97220.97 low1.15 high
ⓘQuick Ratio As of 22 Nov 2026.See CSL Ltd returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
CSL Ltd
Interest Coverage
9.29x
Mid-range vs own history
QoQ 0.0%
YoY −6.4%
now 9.28889.29 low11.21 high
ⓘInterest Coverage As of 22 Nov 2026.See CSL Ltd returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
CSL Ltd
Debt / Equity
0.74x
Mid-range vs own history
QoQ 0.0%
YoY +22.7%
now 0.73640.6 low0.74 high
ⓘDebt / Equity As of 22 Nov 2026.See CSL Ltd returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
CSL Ltd
Piotroski F-Score
5
5
QoQ 0.0%
YoY −28.6%
now 55 low7 high
ⓘPiotroski F-Score As of 22 Nov 2026.See CSL Ltd returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
CSL Ltd
Altman Z-Score
5.44
Mid-range vs own history
QoQ +9.7%
YoY +10.4%
now 5.44043.84 low5.53 high
ⓘAltman Z-Score As of 22 Nov 2026.See CSL Ltd returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  16 members-only factors: Revenue Growth, Earnings Growth, EBITDA Growth, FCF Growth and moreSign up
Accounting Red Flags
  17 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for CSL Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

CSL Ltd fundamentals: income statement, balance sheet & cash flow

CSL Ltd reported revenue of 15.70bn AUD and net income of -2.58bn AUD in FY2026, the year ended 30 June 2026 — revenue up 1.7% and net income down 185.9% on the prior year. Free cash flow was 2.23bn AUD. These figures are as reported in the filings, not restated: 34 fiscal years and 130 quarters of history, back to June 1993.

Revenue (FY2026)
15.70bn AUD
+1.7%
Net income
-2.58bn AUD
-185.9%
Gross margin
47.71%
Free cash flow
2.23bn AUD
-12.3%
Net debt
9.38bn AUD
CSL Ltd income statement, annual, as reported · AUD billions unless stated
AUD billionsFY2026FY2025FY2024FY2023FY2022
Period end30 Jun 202630 Jun 202530 Jun 202430 Jun 202330 Jun 2022
Revenue15.7015.4314.6913.1710.49
Cost of revenue8.217.487.136.474.83
Gross profit7.497.957.566.715.66
Research & development1.221.361.431.221.16
Selling, general & admin.—3.633.373.392.19
Operating income4.012.962.762.102.32
EBITDA5.055.094.773.923.46
Interest expense0.430.390.480.440.16
Pre-tax income-4.093.723.382.662.78
Income tax-1.100.590.660.420.52
Net income-2.583.002.642.192.25

Download CSL Ltd fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.CSL.AU&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 34 fiscal years and 130 quarters, the filing vintages behind each number and API access.
Create free account

Figures in AUD, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on CSL Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

CSL Ltd Trading Strategies

31 backtested tactical asset allocation strategies hold EFA (developed markets outside the US), the closest tradable exposure to CSL Ltd; 22 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 31 strategies holding EFA →

Statistical Distribution of Returns

Plus

How CSL Ltd’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how CSL Ltd behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About CSL Ltd (Australia)

CSL Ltd is a listed security in Australia. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Carlisle Companies Incorporated

Frequently asked questions

What is CSL Ltd?
CSL Ltd is a listed security in Australia. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest CSL Ltd price?
The latest close is 197.29 (21 Nov 2026), -0.01% on the day. The price at the top of the page refreshes during the trading day.
Is CSL Ltd in an uptrend?
As of 21 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (7 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is CSL Ltd?
20-day realised volatility is 16.2% a year (21 Nov 2026), which implies a typical one-standard-deviation move of about 4.7% over a month and 2.3% over a week.
What factors affect CSL Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to CSL Ltd, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade CSL Ltd?
31 backtested tactical asset allocation strategies trade CSL Ltd through EFA; 22 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are CSL Ltd returns analysed?
The Statistical Distribution of Returns section shows the distribution of CSL Ltd daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free CSL Ltd historical data?
In the Free historical data section of this page: the last 10 years of CSL Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free CSL Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of CSL Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.CSL.AU&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20197.29
2026-11-19199.85
2026-11-18199.38
2026-11-17199.55
2026-11-16202.52
2026-11-13202.92
2026-11-12204.54
2026-11-11201.68
2026-11-10200.73
2026-11-09200.77
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. The company's therapeutic areas includes Immunoglobulins, Immunology, Immunology Haematology, Cardiovascular and Renal, and Vaccines. It also licenses CSL intellectual property. It also develops vaccines for the prevention of infectious disease. The company has strategic collaboration with Dutch biotech company VarmX BV for the development of VMX-C001 to help restore blood coagulation in patients requiring urgent surgery; and Alentis Therapeutics AG to develop and commercialise lixudebart for rare kidney and liver diseases. The company was formerly known as Commonwealth Serum Laboratories Limited and later changed its name to CSL Limited in October 1991. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.